{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:24:51Z","timestamp":1790612691920,"version":"4.1.0"},"reference-count":372,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.cytogfr.2005.05.010","type":"journal-article","created":{"date-parts":[[2005,6,28]],"date-time":"2005-06-28T17:13:09Z","timestamp":1119978789000},"page":"441-467","source":"Crossref","is-referenced-by-count":371,"title":["RET tyrosine kinase signaling in development and cancer"],"prefix":"10.1016","volume":"16","author":[{"given":"Elena","family":"Arighi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Borrello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannu","family":"Sariola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2005.05.010_bib1","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1242\/dev.119.4.1005","article-title":"Expression of the c-ret proto-oncogene during mouse embryogenesis","volume":"19","author":"Pachnis","year":"1993","journal-title":"Development"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib2","first-page":"305","article-title":"Developmental expression of the RET protooncogene","volume":"5","author":"Avantaggiato","year":"1994","journal-title":"Cell Growth Differ"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/367380a0","article-title":"Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret","volume":"367","author":"Schuchardt","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1242\/dev.122.1.349","article-title":"Common origin and developmental dependence on c-ret of subsets of enteric and sympathetic neuroblasts","volume":"122","author":"Durbec","year":"1996","journal-title":"Development"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib5","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1126\/science.287.5457.1489","article-title":"Regulation of cell fate decision of undifferentiated spermatogonia by GDNF","volume":"287","author":"Meng","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib6","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1242\/dev.01421","article-title":"Mice expressing a dominant-negative Ret mutation phenocopy human Hirschsprung disease and delineate a direct role of Ret in spermatogenesis","volume":"131","author":"Jain","year":"2004","journal-title":"Development"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib7","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/367378a0","article-title":"Mutations of the RET proto-oncogene in Hirschsprung's disease","volume":"367","author":"Edery","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/367377a0","article-title":"Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease","volume":"367","author":"Romeo","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0092-8674(90)90659-3","article-title":"PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas","volume":"60","author":"Grieco","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib10","first-page":"1821","article-title":"Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET\/PTC1 oncogene in transgenic mice","volume":"12","author":"Santoro","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1210\/en.137.1.375","article-title":"Targeted expression of the ret\/PTC1 oncogene induces papillary thyroid carcinomas","volume":"137","author":"Jhiang","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib12","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/jmg.37.11.817","article-title":"Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis","volume":"37","author":"Hansford","year":"2000","journal-title":"J Med Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0092-8674(85)90115-1","article-title":"Activation of a novel human transforming gene, ret, by DNA rearrangement","volume":"42","author":"Takahashi","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib14","first-page":"1519","article-title":"Human ret proto-oncogene mapped to chromosome 10q11.2","volume":"4","author":"Ishizaka","year":"1989","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib15","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1073\/pnas.021558598","article-title":"Expression pattern of Drosophila ret suggests a common ancestral origin between the metamorphosis precursors in insect endoderm and the vertebrate enteric neurons","volume":"98","author":"Hahn","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib16","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1128\/MCB.7.4.1378","article-title":"ret transforming gene encodes a fusion protein homologous to tyrosine kinases","volume":"7","author":"Takahashi","year":"1987","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib17","first-page":"571","article-title":"Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains","volume":"3","author":"Takahashi","year":"1988","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib18","first-page":"805","article-title":"Isolation of ret proto-oncogene cDNA with an amino-terminal signal sequence","volume":"4","author":"Takahashi","year":"1989","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib19","first-page":"1087","article-title":"cDNA cloning of mouse ret proto-oncogene and its sequence similarity to the cadherin superfamily","volume":"8","author":"Iwamoto","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib20","doi-asserted-by":"crossref","first-page":"35808","DOI":"10.1074\/jbc.M104968200","article-title":"Molecular modeling of the extracellular domain of the RET receptor tyrosine kinase reveals multiple cadherin-like domains and a calcium-binding site","volume":"276","author":"Anders","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib21","first-page":"1736s","article-title":"The phenotypes associated with ret mutations in the multiple endocrine neoplasia type 2 syndrome","volume":"59","author":"Ponder","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib22","first-page":"297","article-title":"Identification of the ret proto-oncogene products in neuroblastoma and leukemia cells","volume":"6","author":"Takahashi","year":"1991","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib23","first-page":"2925","article-title":"Characterization of the ret proto-oncogene products expressed in mouse L cells","volume":"8","author":"Takahashi","year":"1993","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib24","first-page":"97","article-title":"Characterization of ret proto-oncogene mRNAs encoding two isoforms of the protein product in a human neuroblastoma cell line","volume":"5","author":"Tahira","year":"1990","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib25","first-page":"2039","article-title":"Characterization of RET proto-oncogene 3\u2032 splicing variants and polyadenylation sites: a novel C-terminus for RET","volume":"11","author":"Myers","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000059341","article-title":"Conservation of RET proto-oncogene splicing variants and implications for RET isoform function","volume":"95","author":"Carter","year":"2001","journal-title":"Cytogenet Cell Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib27","doi-asserted-by":"crossref","first-page":"34618","DOI":"10.1074\/jbc.M203580200","article-title":"The long and short isoforms of Ret function as independent signaling complexes","volume":"277","author":"Tsui-Pierchala","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib28","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0006-291X(02)00886-0","article-title":"Differential interaction of Enigma protein with the two RET isoforms","volume":"296","author":"Borrello","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib29","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1038\/sj.onc.1207862","article-title":"Differential requirement of Tyr1062 multidocking site by RET isoforms to promote neural cell scattering and epithelial cell branching","volume":"23","author":"Degl\u2019Innocenti","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib30","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1083\/jcb.200404108","article-title":"The neuronal scaffold protein Shank3 mediates signaling and biological function of the receptor tyrosine kinase Ret in epithelial cells","volume":"167","author":"Schuetz","year":"2004","journal-title":"J Cell Biol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib31","doi-asserted-by":"crossref","first-page":"13442","DOI":"10.1074\/jbc.M500507200","article-title":"Distinct turnover of alternatively-spliced isoforms of the RET kinase receptor mediated by differential recruitment of the Cbl ubiquitin ligase","volume":"280","author":"Scott","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib32","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1101\/gad.205001","article-title":"Differential activities of the RET tyrosine kinase receptor isoforms during mammalian embryogenesis","volume":"15","author":"de Graaff","year":"2001","journal-title":"Genes Dev"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib33","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1242\/dev.126.7.1375","article-title":"Dominant effects of RET receptor misexpression and ligand-independent RET signaling on ureteric bud development","volume":"126","author":"Srinivas","year":"1999","journal-title":"Development"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib34","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1038\/sj.onc.1205741","article-title":"RET receptor tyrosine kinase isoforms in kidney function and disease","volume":"21","author":"Lee","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib35","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/381789a0","article-title":"GDNF signalling through the Ret receptor tyrosine kinase","volume":"381","author":"Durbec","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib36","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/381785a0","article-title":"Functional receptor for GDNF encoded by the c-ret proto-oncogene","volume":"381","author":"Trupp","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib37","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0092-8674(00)81311-2","article-title":"GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF","volume":"85","author":"Jing","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib38","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/382080a0","article-title":"Characterization of a multicomponent receptor for GDNF","volume":"382","author":"Treanor","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib39","doi-asserted-by":"crossref","first-page":"10657","DOI":"10.1073\/pnas.93.20.10657","article-title":"Glial cell line-derived neurotrophic factor activates the receptor tyrosine kinase RET and promotes kidney morphogenesis","volume":"93","author":"Vega","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib40","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/384467a0","article-title":"Neurturin, a relative of glial-cell-line-derived neurotrophic factor","volume":"384","author":"Kotzbauer","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0896-6273(00)80453-5","article-title":"Persephin, a novel neurotrophic factor related to GDNF and neurturin","volume":"20","author":"Milbrandt","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib42","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0896-6273(00)80649-2","article-title":"Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRalpha3\u2013RET receptor complex","volume":"21","author":"Baloh","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib43","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/mcne.1999.0754","article-title":"GDNF family neurotrophic factor signaling: four masters, one servant?","volume":"13","author":"Airaksinen","year":"1999","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib44","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/(SICI)1097-0029(19990515\/01)45:4\/5<292::AID-JEMT13>3.0.CO;2-8","article-title":"Other neurotrophic factors: glial cell line-derived neurotrophic factor (GDNF)","volume":"45","author":"Saarma","year":"1999","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib45","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0959-4388(99)00048-3","article-title":"The GDNF family ligands and receptors\u2014implications for neural development","volume":"10","author":"Baloh","year":"2000","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib46","doi-asserted-by":"crossref","first-page":"6968","DOI":"10.1046\/j.1432-1327.2000.01826.x","article-title":"GDNF\u2014a stranger in the TGF-beta superfamily?","volume":"267","author":"Saarma","year":"2000","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib47","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1126\/science.8493557","article-title":"GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons","volume":"260","author":"Lin","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib48","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/373335a0","article-title":"Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo","volume":"373","author":"Tomac","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib49","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1126\/science.7973664","article-title":"GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle","volume":"266","author":"Henderson","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib50","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00001756-199412300-00030","article-title":"Glial cell line-derived neurotrophic factor (GDNF), a new neurotrophic factor for motoneurones","volume":"6","author":"Zurn","year":"1994","journal-title":"Neuroreport"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib51","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/373344a0","article-title":"Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF","volume":"373","author":"Oppenheim","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib52","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/373341a0","article-title":"In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons","volume":"373","author":"Yan","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib53","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/0896-6273(95)90024-1","article-title":"GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo","volume":"15","author":"Arenas","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib54","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0896-6273(95)90173-6","article-title":"GDNF is an age-specific survival factor for sensory and autonomic neurons","volume":"15","author":"Buj-Bello","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib55","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/jnr.490400217","article-title":"Glial cell line-derived neurotrophic factor stimulates fiber formation and survival in cultured neurons from peripheral autonomic ganglia","volume":"40","author":"Ebendal","year":"1995","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib56","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1083\/jcb.130.1.137","article-title":"Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons","volume":"130","author":"Trupp","year":"1995","journal-title":"J Cell Biol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib57","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0168-9525(01)02420-9","article-title":"The RET receptor: function in development and dysfunction in congenital malformation","volume":"17","author":"Mani\u00e9","year":"2001","journal-title":"Trends Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib58","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn812","article-title":"The GDNF family: signalling, biological functions and therapeutic value","volume":"3","author":"Airaksinen","year":"2002","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib59","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/382073a0","article-title":"Defects in enteric innervation and kidney development in mice lacking GDNF","volume":"382","author":"Pichel","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib60","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/382076a0","article-title":"Renal and neuronal abnormalities in mice lacking GDNF","volume":"382","author":"Moore","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib61","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1242\/dev.124.20.4077","article-title":"Glial-cell-line-derived neurotrophic factor is required for bud initiation from ureteric epithelium","volume":"124","author":"Sainio","year":"1997","journal-title":"Development"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib62","first-page":"413","article-title":"GDNF and its receptors in the regulation of the ureteric branching","volume":"43","author":"Sariola","year":"1999","journal-title":"Int J Dev Biol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib63","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0166-2236(98)01266-1","article-title":"Emerging themes in structural biology of neurotrophic factors","volume":"21","author":"Ib\u00e1\u00f1ez","year":"1998","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib64","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/exnr.2000.7571","article-title":"Heparin coinfusion during convection-enhanced delivery (CED) increases the distribution of the glial-derived neurotrophic factor (GDNF) ligand family in rat striatum and enhances the pharmacological activity of neurturin","volume":"168","author":"Hamilton","year":"2001","journal-title":"Exp Neurol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib65","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0896-6273(00)80318-9","article-title":"TrnR2, a novel receptor that mediates neurturin and GDNF signaling through Ret","volume":"18","author":"Baloh","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib66","doi-asserted-by":"crossref","first-page":"33111","DOI":"10.1074\/jbc.272.52.33111","article-title":"GFRalpha-2 and GFRalpha-3 are two new receptors for ligands of the GDNF family","volume":"272","author":"Jing","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib67","doi-asserted-by":"crossref","first-page":"9344","DOI":"10.1074\/jbc.M008279200","article-title":"Human glial cell line-derived neurotrophic factor receptor alpha 4 is the receptor for persephin and is predominantly expressed in normal and malignant thyroid medullary cells","volume":"276","author":"Lindahl","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib68","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1074\/jbc.M107992200","article-title":"Coordinated activation of autophosphorylation sites in the RET receptor tyrosine kinase: importance of tyrosine 1062 for GDNF mediated neuronal differentiation and survival","volume":"277","author":"Coulpier","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib69","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1242\/jcs.00786","article-title":"Novel functions and signalling pathways for GDNF","volume":"116","author":"Sariola","year":"2003","journal-title":"J Cell Sci"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib70","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1093\/emboj\/18.21.5901","article-title":"Distinct structural elements in GDNF mediate binding to GFRalpha1 and activation of the GFRalpha1-c-Ret receptor complex","volume":"18","author":"Eketj\u00e4ll","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib71","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/42408","article-title":"Functional rafts in cell membranes","volume":"387","author":"Simons","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib72","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1006\/scdb.1998.0258","article-title":"Protein and lipid sorting from the trans-Golgi network to the plasma membrane in polarized cells","volume":"9","author":"Ikonen","year":"1998","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib73","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/35036052","article-title":"Lipid rafts and signal transduction","volume":"1","author":"Simons","year":"2000","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib74","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-5793(99)01590-2","article-title":"GDNF triggers a novel ret-independent Src kinase family-coupled signaling via a GPI-linked GDNF receptor alpha1","volume":"463","author":"Poteryaev","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib75","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0896-6273(00)81064-8","article-title":"GFRalpha-mediated localization of RET to lipid rafts is required for effective downstream signaling, differentiation, and neuronal survival","volume":"25","author":"Tansey","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib76","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1523\/JNEUROSCI.17-10-03554.1997","article-title":"Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-alpha indicates multiple mechanisms of trophic actions in the adult rat CNS","volume":"17","author":"Trupp","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib77","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1523\/JNEUROSCI.18-12-04684.1998","article-title":"Expression of GDNF family receptor components during development: implications in the mechanisms of interaction","volume":"18","author":"Yu","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib78","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/42722","article-title":"A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor","volume":"387","author":"Klein","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib79","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1242\/dev.127.20.4383","article-title":"Developmental regulation of GDNF response and receptor expression in the enteric nervous system","volume":"127","author":"Worley","year":"2000","journal-title":"Development"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib80","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0896-6273(01)00188-X","article-title":"Released GFRalpha1 potentiates downstream signaling, neuronal survival, and differentiation via a novel mechanism of recruitment of c-Ret to lipid rafts","volume":"29","author":"Paratcha","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib81","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0959-4388(02)00363-X","article-title":"Lipid rafts and the control of neurotrophic factor signaling in the nervous system: variations on a theme","volume":"12","author":"Paratcha","year":"2002","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib82","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0166-2236(02)02215-4","article-title":"Lipid rafts in neuronal signaling and function","volume":"25","author":"Tsui-Pierchala","year":"2002","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib83","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.febslet.2004.06.007","article-title":"PSPN\/GFRalpha4 has a significantly weaker capacity than GDNF\/GFRalpha1 to recruit RET to rafts, but promotes neuronal survival and neurite outgrowth","volume":"569","author":"Yang","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib84","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1083\/jcb.200203115","article-title":"TGFbeta induces GDNF responsiveness in neurons by recruitment of GFRalpha1 to the plasma membrane","volume":"159","author":"Peterziel","year":"2002","journal-title":"J Cell Biol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib85","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1242\/jcs.00114","article-title":"Signalling by glial cell line-derived neurotrophic factor (GDNF) requires heparan sulphate glycosaminoglycan","volume":"115","author":"Barnett","year":"2002","journal-title":"J Cell Sci"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib86","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1097\/00001756-200210280-00016","article-title":"Heparin facilitates glial cell line-derived neurotrophic factor signal transduction","volume":"13","author":"Tanaka","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib87","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1242\/dev.121.5.1507","article-title":"Sulphated proteoglycan is required for collecting duct growth and branching but not nephron formation during kidney development","volume":"121","author":"Davies","year":"1995","journal-title":"Development"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib88","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1101\/gad.12.12.1894","article-title":"Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase","volume":"12","author":"Bullock","year":"1998","journal-title":"Genes Dev"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib89","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0378-5955(98)00095-1","article-title":"Guinea pig auditory neurons are protected by glial cell line-derived growth factor from degeneration after noise trauma","volume":"124","author":"Ylikoski","year":"1998","journal-title":"Heart Res"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib90","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1046\/j.1460-9568.1999.00513.x","article-title":"GDNF family ligands and receptors are differentially regulated after brain insults in the rat","volume":"11","author":"Kokaia","year":"1999","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib91","doi-asserted-by":"crossref","first-page":"20885","DOI":"10.1074\/jbc.274.30.20885","article-title":"Ret-dependent and -independent mechanisms of glial cell line-derived neurotrophic factor signaling in neuronal cells","volume":"274","author":"Trupp","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib92","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1083\/jcb.200212174","article-title":"GDNF promotes tubulogenesis of GFRalpha1-expressing MDCK cells by Src-mediated phosphorylation of Met receptor tyrosine kinase","volume":"161","author":"Popsueva","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib93","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0092-8674(03)00435-5","article-title":"The neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family ligands","volume":"113","author":"Paratcha","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib94","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0197-4580(02)00047-7","article-title":"Integrin alphav and NCAM mediate the effects of GDNF on DA neuron survival, outgrowth, DA turnover and motor activity in rats","volume":"24","author":"Chao","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib95","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.neuron.2004.10.032","article-title":"GFRalpha1 expression in cells lacking RET is dispensable for organogenesis and nerve regeneration","volume":"44","author":"Enomoto","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib96","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0896-6273(01)00585-2","article-title":"NGF utilizes c-Ret via a novel GFL-independent, inter-RTK signaling mechanism to maintain the trophic status of mature sympathetic neurons","volume":"33","author":"Tsui-Pierchala","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib97","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1242\/dev.122.6.1919","article-title":"Renal agenesis and hypodysplasia in ret-k-mutant mice result from defects in ureteric bud development","volume":"122","author":"Schuchardt","year":"1996","journal-title":"Development"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib98","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0896-6273(00)80514-0","article-title":"GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney","volume":"21","author":"Cacalano","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib99","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0896-6273(00)80541-3","article-title":"GFR alpha1-deficient mice have deficits in the enteric nervous system and kidneys","volume":"21","author":"Enomoto","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib100","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1242\/dev.126.12.2785","article-title":"Signalling by the RET receptor tyrosine kinase and its role in the development of the mammalian enteric nervous system","volume":"126","author":"Taraviras","year":"1999","journal-title":"Development"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib101","first-page":"137S","article-title":"The effect of the ret-mutation on the normal development of the central and parasympathetic nervous systems","volume":"1","author":"Marcos","year":"1996","journal-title":"Int J Dev Biol (Suppl)"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib102","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1242\/dev.127.22.4877","article-title":"Development of cranial parasympathetic ganglia requires sequential actions of GDNF and neurturin","volume":"127","author":"Enomoto","year":"2000","journal-title":"Development"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib103","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1046\/j.1460-9568.2000.00292.x","article-title":"Distinct roles for GFRalpha1 and GFRalpha2 signalling in different cranial parasympathetic ganglia in vivo","volume":"12","author":"Rossi","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib104","first-page":"191","article-title":"Spatial and temporal expression of the ret proto-oncogene product in embryonic, infant and adult rat tissues","volume":"10","author":"Tsuzuki","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/dbio.1998.8987","article-title":"A single rostrocaudal colonization of the rodent intestine by enteric neuron precursors is revealed by the expression of Phox2b, Ret, and p75 and by explants grown under the kidney capsule or in organ culture","volume":"202","author":"Young","year":"1998","journal-title":"Dev Biol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib106","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1523\/JNEUROSCI.18-08-03059.1998","article-title":"A distinct subgroup of small DRG cells express GDNF receptor components and GDNF is protective for these neurons after nerve injury","volume":"18","author":"Bennett","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib107","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF00849241","article-title":"Early organogenesis of the kidney","volume":"1","author":"Sax\u00e9n","year":"1987","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib108","series-title":"The kidney: from normal development to congenital disease","first-page":"195","article-title":"Formation and development of nephrons","author":"Cho","year":"2003"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib109","series-title":"The kidney: from normal development to congenital disease","first-page":"181","article-title":"Fates of the metanephric mesenchyme","author":"Sariola","year":"2003"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib110","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0925-4773(95)00464-5","article-title":"Embryonic expression of glial cell-line derived neurotrophic factor (GDNF) suggests multiple developmental roles in neural differentiation and epithelial\u2013mesenchymal interactions","volume":"54","author":"Hellmich","year":"1996","journal-title":"Mech Dev"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib111","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1460-9568.1996.tb01267.x","article-title":"Localization of glial cell line-derived neurotrophic factor (GDNF) mRNA in embryonic rat by in situ hybridization","volume":"8","author":"Suvanto","year":"1996","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib112","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.devcel.2004.11.008","article-title":"The role of GDNF\/Ret signaling in ureteric bud cell fate and branching morphogenesis","volume":"8","author":"Shakya","year":"2005","journal-title":"Dev Cell"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib113","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.devcel.2004.12.004","article-title":"Sprouty1 is a critical regulator of GDNF\/RET-mediated kidney induction","volume":"8","author":"Basson","year":"2005","journal-title":"Dev Cell"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib114","doi-asserted-by":"crossref","first-page":"7330","DOI":"10.1073\/pnas.96.13.7330","article-title":"Branching morphogenesis independent of mesenchymal\u2013epithelial contact in the developing kidney","volume":"96","author":"Qiao","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib115","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1006\/mcne.2002.1104","article-title":"Role of heparin-binding growth-associated molecule (HB-GAM) in hippocampal LTP and spatial learning revealed by studies on overexpressing and knockout mice","volume":"20","author":"Pavlov","year":"2002","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib116","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0896-6273(00)81087-9","article-title":"Gene targeting reveals a critical role for neurturin in the development and maintenance of enteric, sensory, and parasympathetic neurons","volume":"22","author":"Heuckeroth","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib117","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0896-6273(00)81086-7","article-title":"Retarded growth and deficits in the enteric and parasympathetic nervous system in mice lacking GFR alpha2, a functional neurturin receptor","volume":"22","author":"Rossi","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib118","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/367455a0","article-title":"Inactivation of the N-CAM gene in mice results in size reduction of the olfactory bulb and deficits in spatial learning","volume":"367","author":"Cremer","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib119","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ydbio.2004.12.006","article-title":"Isolation of male germ-line stem cells; influence of GDNF","volume":"279","author":"Hofmann","year":"2005","journal-title":"Dev Biol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0303-7207(01)00649-9","article-title":"Transient disruption of spermatogenesis by deregulated expression of neurturin in testis","volume":"184","author":"Meng","year":"2001","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib121","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1074\/jbc.271.10.5309","article-title":"Oncogenic RET receptors display different autophosphorylation sites and substrate binding specificities","volume":"271","author":"Liu","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib122","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1074\/jbc.273.9.4909","article-title":"Signal transduction pathways activated by RET oncoproteins in PC12 pheochromocytoma cells","volume":"273","author":"Xing","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib123","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1210\/jc.85.10.3898","article-title":"Tyrosines 1015 and 1062 are in vivo autophosphorylation sites in ret and ret-derived oncoproteins","volume":"85","author":"Salvatore","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib124","doi-asserted-by":"crossref","first-page":"14213","DOI":"10.1074\/jbc.M312600200","article-title":"Identification of RET autophosphorylation sites by mass spectrometry","volume":"279","author":"Kawamoto","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib125","doi-asserted-by":"crossref","first-page":"21461","DOI":"10.1074\/jbc.270.37.21461","article-title":"The Ret receptor protein tyrosine kinase associates with the SH2-containing adapter protein Grb10","volume":"270","author":"Pandey","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib126","doi-asserted-by":"crossref","first-page":"10607","DOI":"10.1074\/jbc.271.18.10607","article-title":"Direct association between the Ret receptor tyrosine kinase and the Src homology 2-containing adapter protein Grb7","volume":"271","author":"Pandey","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib127","doi-asserted-by":"crossref","first-page":"18262","DOI":"10.1074\/jbc.M400505200","article-title":"Tyrosine 981, a novel ret autophosphorylation site, binds c-Src to mediate neuronal survival","volume":"279","author":"Encinas","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib128","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1128\/MCB.16.5.2151","article-title":"The full oncogenic activity of Ret\/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma","volume":"16","author":"Borrello","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib129","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.onc.1202046","article-title":"Grb2 binding to the different isoforms of Ret tyrosine kinase","volume":"17","author":"Alberti","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib130","first-page":"481","article-title":"Identification of tyrosine residues that are essential for transforming activity of the ret proto-oncogene with MEN 2A or MEN 2B mutation","volume":"12","author":"Iwashita","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib131","doi-asserted-by":"crossref","first-page":"17644","DOI":"10.1074\/jbc.271.30.17644","article-title":"A mutation at tyrosine 1062 in MEN 2A-Ret and MEN 2B-Ret impairs their transforming activity and association with shc adaptor proteins","volume":"271","author":"Asai","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib132","doi-asserted-by":"crossref","first-page":"12691","DOI":"10.1074\/jbc.271.22.12691","article-title":"Mitogenic signaling by Ret\/ptc2 requires association with enigma via a LIM domain","volume":"271","author":"Durick","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib133","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/sj.onc.1200896","article-title":"Identification of Shc docking site on Ret tyrosine kinase","volume":"14","author":"Arighi","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib134","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/sj.onc.1200894","article-title":"RET alternate splicing influences the interaction of activated RET with the SH2 and PTB domains of Shc, and the SH2 domain of Grb2","volume":"14","author":"Lorenzo","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib135","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1006\/bbrc.1997.7225","article-title":"Characterization of Ret\u2013Shc\u2013Grb2 complex induced by GDNF, MEN 2A, and MEN 2B mutations","volume":"237","author":"Ohiwa","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib136","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0303-7207(00)00283-5","article-title":"Ret oncogene signal transduction via a IRS-2\/PI 3-kinase\/PKB and a SHC\/Grb-2 dependent pathway: possible implication for transforming activity in NIH3T3 cells","volume":"167","author":"Hennige","year":"2000","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib137","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1038\/sj.onc.1204290","article-title":"Identification of SNT\/FRS2 docking site on RET receptor tyrosine kinase and its role for signal transduction","volume":"20","author":"Kurokawa","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib138","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1128\/MCB.21.13.4177-4187.2001","article-title":"Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade","volume":"21","author":"Melillo","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib139","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.onc.1204049","article-title":"The insulin receptor substrate (IRS)-1 recruits phosphatidylinositol 3-kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret","volume":"20","author":"Melillo","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib140","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1083\/jcb.200102032","article-title":"Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation","volume":"154","author":"Grimm","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib141","doi-asserted-by":"crossref","first-page":"32781","DOI":"10.1074\/jbc.M202336200","article-title":"Role of Dok1 in cell signaling mediated by RET tyrosine kinase","volume":"277","author":"Murakami","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib142","doi-asserted-by":"crossref","first-page":"7351","DOI":"10.1128\/MCB.22.20.7351-7363.2002","article-title":"The neuron-specific Rai (ShcC) adaptor protein inhibits apoptosis by coupling Ret to the phosphatidylinositol 3-kinase\/Akt signaling pathway","volume":"22","author":"Pelicci","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib143","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1038\/sj.onc.1206475","article-title":"Protein kinase Calpha activation by RET: evidence for a negative feedback mechanism controlling RET tyrosine kinase","volume":"22","author":"Andreozzi","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib144","doi-asserted-by":"crossref","first-page":"42072","DOI":"10.1074\/jbc.M403726200","article-title":"Dok-6, a novel p62 Dok family member, promotes Ret-mediated neurite outgrowth","volume":"279","author":"Crowder","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib145","doi-asserted-by":"crossref","first-page":"39159","DOI":"10.1074\/jbc.M006908200","article-title":"Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase","volume":"275","author":"Besset","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib146","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1038\/sj.onc.1203799","article-title":"Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor","volume":"19","author":"Hayashi","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib147","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1006\/bbrc.2001.4338","article-title":"Activation of BMK1 via tyrosine 1062 in RET by GDNF and MEN 2A mutation","volume":"281","author":"Hayashi","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib148","doi-asserted-by":"crossref","first-page":"8026","DOI":"10.1128\/MCB.24.18.8026-8036.2004","article-title":"A targeting mutation of tyrosine 1062 in ret causes a marked decrease of enteric neurons and renal hypoplasia","volume":"24","author":"Jijiwa","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib149","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1038\/sj.onc.1204462","article-title":"Key role of Shc signaling in the transforming pathway triggered by Ret\/ptc2 oncoprotein","volume":"20","author":"Mercalli","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib150","doi-asserted-by":"crossref","first-page":"19114","DOI":"10.1074\/jbc.M200643200","article-title":"Novel mechanism of regulation of Rac activity and lamellipodia formation by RET tyrosine kinase","volume":"277","author":"Fukuda","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib151","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1038\/sj.onc.1204715","article-title":"MEN 2A-RET-induced cellular transformation by activation of STAT3","volume":"20","author":"Schuringa","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib152","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1210\/me.2002-0402","article-title":"RET\/PTC (rearranged in transformation\/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1","volume":"17","author":"Kim","year":"2003","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib153","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1210\/me.2004-0168","article-title":"Regulation of STAT1 and STAT1-dependent genes by RET\/PTC (rearranged in transformation\/papillary thyroid carcinoma) oncogenic tyrosine kinases","volume":"18","author":"Hwang","year":"2004","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib154","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1128\/MCB.14.1.663","article-title":"An epidermal growth factor receptor\/ret chimera generates mitogenic and transforming signals: evidence for a ret-specific signaling pathway","volume":"14","author":"Santoro","year":"1994","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib155","first-page":"2207","article-title":"Ret receptor tyrosine kinase activates extracellular signal-regulated kinase 2 in SK-N-MC cells","volume":"11","author":"van Weering","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib156","doi-asserted-by":"crossref","first-page":"23619","DOI":"10.1074\/jbc.271.39.23619","article-title":"Glial cell line-derived neurotrophic factor signals through the RET receptor and activates mitogen-activated protein kinase","volume":"271","author":"Worby","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib157","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1074\/jbc.272.1.249","article-title":"Glial cell line-derived neurotrophic factor induces Ret-mediated lamellipodia formation","volume":"272","author":"van Weering","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib158","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1074\/jbc.275.5.3568","article-title":"Transforming ability of MEN 2A-RET requires activation of the phosphatidylinositol 3-kinase\/AKT signaling pathway","volume":"275","author":"Segouffin-Cariou","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib159","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.bbrc.2004.08.095","article-title":"Biochemical and biological responses induced by coupling of Gab1 to phosphatidylinositol 3-kinase in RET-expressing cells","volume":"323","author":"Maeda","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib160","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1038\/sj.onc.1201778","article-title":"Signalling of the Ret receptor tyrosine kinase through the c-Jun NH2-terminal protein kinases (JNKS): evidence for a divergence of the ERKs and JNKs pathways induced by Ret","volume":"16","author":"Chiariello","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib161","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1365-2796.2003.01167.x","article-title":"Cell signalling and gene expression mediated by RET tyrosine kinase","volume":"253","author":"Kurokawa","year":"2003","journal-title":"J Intern Med"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib162","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0002-9440(10)64176-4","article-title":"Characterization of gene expression induced by RET with MEN 2A or MEN 2B mutation","volume":"161","author":"Watanabe","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib163","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1158\/0008-5472.CAN-03-3801","article-title":"Expression profiles provide insights into early malignant potential and skeletal abnormalities in multiple endocrine neoplasia type 2B syndrome tumors","volume":"64","author":"Jain","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib164","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1158\/0008-5472.CAN-03-3605","article-title":"The RET receptor is linked to stress response pathways","volume":"64","author":"Myers","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib165","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/1097-0142(19890301)63:5<908::AID-CNCR2820630520>3.0.CO;2-I","article-title":"The WHO histological classification of thyroid tumors: a commentary on the second edition","volume":"63","author":"Hedinger","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib166","unstructured":"Rosai J, Carcangiu ML, DeLellis RA. Atlas of tumor pathology. Tumors of the thyroid gland, 3rd series. Fascicle 5. Washington, DC: Armed Forces Institute of Pathology; 1992."},{"key":"10.1016\/j.cytogfr.2005.05.010_bib167","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1098-2264(199605)16:1<1::AID-GCC1>3.0.CO;2-4","article-title":"Cytogenetics and molecular genetics of carcinomas arising from thyroid epithelial follicular cells","volume":"16","author":"Pierotti","year":"1996","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib168","doi-asserted-by":"crossref","first-page":"5590","DOI":"10.1038\/sj.onc.1203857","article-title":"The RET proto-oncogene in human cancers","volume":"19","author":"Jhiang","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib169","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/jcp.10252","article-title":"RET and NTRK1 proto-oncogenes in human diseases","volume":"195","author":"Alberti","year":"2003","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib170","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0304-3835(03)00456-7","article-title":"RET and neuroendocrine tumors","volume":"204","author":"Ichihara","year":"2004","journal-title":"Cancer Lett"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib171","doi-asserted-by":"crossref","first-page":"5448","DOI":"10.1210\/en.2004-0922","article-title":"Minireview: RET: normal and abnormal functions","volume":"145","author":"Santoro","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib172","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1749-6632.2002.tb04102.x","article-title":"Molecular mechanisms of RET activation in human cancer","volume":"963","author":"Santoro","year":"2002","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib173","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/gcc.10112","article-title":"Regulatory subunit type I-alpha of protein kinase A (PRKAR1A): a tumor-suppressor gene for sporadic thyroid cancer","volume":"35","author":"Sandrini","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib174","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/sj.onc.1206981","article-title":"H4(D10S170), a gene frequently rearranged with RET in papillary thyroid carcinomas: functional characterization","volume":"23","author":"Celetti","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib175","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mrfmmm.2004.09.010","article-title":"Characterization of novel non-clonal intrachromosomal rearrangements between the H4 and PTEN genes (H4\/PTEN) in human thyroid cell lines and papillary thyroid cancer specimens","volume":"570","author":"Puxeddu","year":"2005","journal-title":"Mutat Res"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib176","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2559.1993.tb01227.x","article-title":"Radiation-induced thyroid cancer","volume":"23","author":"Williams","year":"1993","journal-title":"Histopathology"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib177","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/32076","article-title":"Thyroid cancer risk to children calculated","volume":"392","author":"Jacob","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib178","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0140-6736(94)93024-4","article-title":"Activated RET oncogene in thyroid cancers of children from areas contaminated by Chernobyl accident","volume":"344","author":"Ito","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib179","first-page":"5617","article-title":"Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident","volume":"55","author":"Fugazzola","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib180","first-page":"2459","article-title":"High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident","volume":"11","author":"Klugbauer","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib181","first-page":"1690","article-title":"Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children","volume":"57","author":"Nikiforov","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib182","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/(SICI)1097-0215(19990105)80:1<32::AID-IJC7>3.0.CO;2-L","article-title":"Distinct frequency of ret rearrangements in papillary thyroid carcinomas of children and adults from Belarus","volume":"80","author":"Smida","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib183","first-page":"1093","article-title":"Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-Chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications","volume":"6","author":"Rabes","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib184","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/sj.onc.1200206","article-title":"High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation","volume":"15","author":"Bounacer","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib185","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1210\/jc.87.8.3941","article-title":"RET expression in papillary thyroid cancer from patients irradiated in childhood for benign conditions","volume":"87","author":"Collins","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib186","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1210\/jc.84.11.4232","article-title":"High prevalence of RET\/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET\/PTC3 and the solid-follicular variant","volume":"84","author":"Thomas","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib187","first-page":"5523","article-title":"The RET\/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids","volume":"58","author":"Powell","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib188","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0002-9440(10)64368-4","article-title":"Potent mitogenicity of the RET\/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma","volume":"160","author":"Basolo","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib189","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1158\/0008-5472.CAN-03-3918","article-title":"Regulation of p27Kip1 protein levels contributes to mitogenic effects of the RET\/PTC kinase in thyroid carcinoma cells","volume":"64","author":"Vitagliano","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib190","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1038\/sj.onc.1205226","article-title":"Glial cell line-derived neurotrophic factor induces proliferative inhibition of NT2\/D1 cells through RET-mediated up-regulation of the cyclin-dependent kinase inhibitor p27(kip1)","volume":"21","author":"Baldassarre","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib191","doi-asserted-by":"crossref","first-page":"5958","DOI":"10.1038\/sj.onc.1207790","article-title":"Functional expression of the CXCR4 chemokine receptor is induced by RET\/PTC oncogenes and is a common event in human papillary thyroid carcinomas","volume":"23","author":"Castellone","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib192","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1038\/sj.onc.1207322","article-title":"Autocrine stimulation by osteopontin plays a pivotal role in the expression of the mitogenic and invasive phenotype of RET\/PTC-transformed thyroid cells","volume":"23","author":"Castellone","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib193","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1126\/science.287.5454.860","article-title":"Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity","volume":"287","author":"Ashkar","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib194","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1126\/science.1062960","article-title":"The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease","volume":"294","author":"Chabas","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib195","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/sj.onc.1206112","article-title":"Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET\/PTC oncogenes","volume":"22","author":"Castellone","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib196","doi-asserted-by":"crossref","first-page":"8166","DOI":"10.1038\/sj.onc.1205938","article-title":"The roles of phosphotyrosines-294, -404, and -451 in RET\/PTC1-induced thyroid tumor formation","volume":"21","author":"Buckwalter","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib197","first-page":"1207","article-title":"RET\/PTC oncogene activation is an early event in thyroid carcinogenesis","volume":"11","author":"Viglietto","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib198","first-page":"287","article-title":"RET\/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes","volume":"4","author":"Tallini","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib199","first-page":"367","article-title":"Papillary microcarcinoma of the thyroid: a clinico-pathologic and prognostic review","volume":"14","author":"Nasir","year":"2000","journal-title":"In Vivo"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib200","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/labinvest.3780377","article-title":"Frequent RET rearrangements in thyroid papillary microcarcinoma detected by interphase fluorescence in situ hybridization","volume":"81","author":"Corvi","year":"2001","journal-title":"Lab Invest"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib201","first-page":"198","article-title":"Detection of a novel type of RET rearrangement (PTC5) in thyroid carcinomas after Chernobyl and analysis of the involved RET-fused gene RFG5","volume":"58","author":"Klugbauer","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib202","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0002-9440(10)65731-8","article-title":"Papillary thyroid carcinoma oncogene (RET\/PTC) alters the nuclear envelope and chromatin structure","volume":"153","author":"Fischer","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib203","first-page":"2940","article-title":"In vitro irradiation is able to cause RET oncogene rearrangement","volume":"53","author":"Ito","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib204","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/sj.onc.1201313","article-title":"Continued expression of a tissue specific activated oncogene in the early steps of radiation-induced human thyroid carcinogenesis","volume":"15","author":"Mizuno","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib205","doi-asserted-by":"crossref","first-page":"6330","DOI":"10.1038\/sj.onc.1203019","article-title":"Chromosomal breakpoint positions suggest a direct role for radiation in inducing illegitimate recombination between the ELE1 and RET genes in radiation-induced thyroid carcinomas","volume":"18","author":"Nikiforov","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib206","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1126\/science.290.5489.138","article-title":"Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells","volume":"290","author":"Nikiforova","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib207","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3835(01)00596-1","article-title":"RET rearrangements in familial papillary thyroid carcinomas","volume":"170","author":"Corvi","year":"2001","journal-title":"Cancer Lett"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib208","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1210\/jc.84.6.2157","article-title":"Genetic heterogeneity in familial nonmedullary thyroid carcinoma: exclusion of linkage to RET, MNG1, and TCO in 56 families, NMTC Consortium","volume":"84","author":"Lesueur","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib209","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/106689690000800305","article-title":"ret\/PTC-1 activation in Hashimoto thyroiditis","volume":"8","author":"Sheils","year":"2000","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib210","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1053\/hupa.2001.21138","article-title":"Pathologic features of Hashimoto's-associated papillary thyroid carcinomas","volume":"32","author":"Di Pasquale","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib211","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2559.2002.01467.x","article-title":"Hashimoto's thyroiditis shares features with early papillary thyroid carcinoma","volume":"41","author":"Arif","year":"2002","journal-title":"Histopathology"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib212","first-page":"816","article-title":"Occult micropapillary carcinoma associated with benign follicular thyroid disease and unrelated thyroid neoplasms","volume":"9","author":"Fink","year":"1996","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib213","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/BF03349721","article-title":"Rearrangements of TRK proto-oncogene in papillary thyroid carcinomas","volume":"18","author":"Pierotti","year":"1995","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib214","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/319743a0","article-title":"A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences","volume":"319","author":"Martin-Zanca","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib215","first-page":"237","article-title":"TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas","volume":"7","author":"Greco","year":"1992","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib216","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1128\/MCB.15.11.6118","article-title":"The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain","volume":"15","author":"Greco","year":"1995","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib217","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/(SICI)1098-2264(199706)19:2<112::AID-GCC7>3.0.CO;2-1","article-title":"Chromosome 1 rearrangements involving the genes TPR and NTRK1 produce structurally different thyroid-specific TRK oncogenes","volume":"19","author":"Greco","year":"1997","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib218","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1172\/JCI23237","article-title":"Oncogenic AKAP9\u2013BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer","volume":"115","author":"Ciampi","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib219","doi-asserted-by":"crossref","first-page":"17267","DOI":"10.1074\/jbc.274.24.17267","article-title":"Characterization of a novel giant scaffolding protein, CG-NAP, that anchors multiple signaling enzymes to centrosome and the Golgi apparatus","volume":"274","author":"Takahashi","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib220","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1172\/JCI200523987","article-title":"A new mechanism of BRAF activation in human thyroid papillary carcinomas","volume":"115","author":"Fusco","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib221","first-page":"1454","article-title":"High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET\/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma","volume":"63","author":"Kimura","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib222","first-page":"4561","article-title":"High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines","volume":"63","author":"Xu","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib223","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1210\/jc.2003-031425","article-title":"BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas","volume":"89","author":"Puxeddu","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib224","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nrc1434","article-title":"Switching on kinases: oncogenic activation of BRAF and the PDGFR family","volume":"4","author":"Dibb","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2003.12.004","article-title":"Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas","volume":"209","author":"Nikiforova","year":"2004","journal-title":"Cancer Lett"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib226","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1210\/jc.2003-032224","article-title":"BRAF mutations are not a major event in post-chernobyl childhood thyroid carcinomas","volume":"89","author":"Lima","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib227","doi-asserted-by":"crossref","first-page":"7436","DOI":"10.1038\/sj.onc.1207980","article-title":"Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer","volume":"23","author":"Frattini","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib228","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1210\/mend-4-10-1474","article-title":"Point mutations of ras oncogenes are an early event in thyroid tumorigenesis","volume":"4","author":"Namba","year":"1990","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib229","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-2265.1999.00704.x","article-title":"Prevalence of Ras mutations in thyroid neoplasia","volume":"50","author":"Esapa","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib230","first-page":"494","article-title":"Multiple endocrine neoplasia syndromes revisited. Clinical, morphologic, and molecular features","volume":"72","author":"DeLellis","year":"1995","journal-title":"Lab Invest"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib231","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/jnci\/87.20.1515","article-title":"RET gene and its implications for cancer","volume":"87","author":"Goodfellow","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib232","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0140-6736(03)12488-9","article-title":"Thyroid carcinoma","volume":"361","author":"Sherman","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib233","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jc.86.12.5658","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib234","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.276.19.1575","article-title":"The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2, International RET mutation consortium analysis","volume":"276","author":"Eng","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib235","first-page":"144","article-title":"Cutaneous lichen amyloidosis associated with multiple endocrine neoplasia type 2A","volume":"37","author":"Nunziata","year":"1989","journal-title":"Henry Ford Hosp Med J"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib236","first-page":"147","article-title":"Familial cutaneous lichen amyloidosis in association with multiple endocrine neoplasia type 2A: a new variant","volume":"37","author":"Donovan","year":"1989","journal-title":"Henry Ford Hosp Med J"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib237","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00005176-198212000-00027","article-title":"Hirschsprung's disease in a family with multiple endocrine neoplasia type 2","volume":"1","author":"Verdy","year":"1982","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib238","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1093\/hmg\/3.12.2163","article-title":"Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene","volume":"3","author":"Mulligan","year":"1994","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib239","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/hmg\/7.1.129","article-title":"Hirschsprung disease in MEN 2A: increased spectrum of RET exon 10 genotypes and strong genotype\u2013phenotype correlation","volume":"7","author":"Decker","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib240","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/hmg\/2.7.851","article-title":"Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC","volume":"2","author":"Donis-Keller","year":"1993","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib241","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/363458a0","article-title":"Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A","volume":"363","author":"Mulligan","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib242","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1073\/pnas.91.4.1579","article-title":"Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B","volume":"91","author":"Carlson","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib243","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/hmg\/3.2.237","article-title":"Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours","volume":"3","author":"Eng","year":"1994","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib244","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/367375a0","article-title":"A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma","volume":"367","author":"Hofstra","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib245","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1126\/science.7824936","article-title":"Activation of RET as a dominant transforming gene by germline mutations of MEN 2A and MEN 2B","volume":"267","author":"Santoro","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib246","first-page":"2419","article-title":"RET activation by germline MEN 2A and MEN 2B mutations","volume":"11","author":"Borrello","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib247","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1128\/MCB.15.3.1613","article-title":"Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations","volume":"15","author":"Asai","year":"1995","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib248","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1073\/pnas.94.7.3330","article-title":"Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation","volume":"94","author":"Michiels","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib249","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/sj.onc.1202376","article-title":"Ganglioneuromas and renal anomalies are induced by activated RET(MEN 2B) in transgenic mice","volume":"18","author":"Sweetser","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib250","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/S0002-9440(10)65534-4","article-title":"Sympathoadrenal hyperplasia causes renal malformations in Ret(MEN 2B)-transgenic mice","volume":"155","author":"Gestblom","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib251","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1038\/sj.onc.1203648","article-title":"Multiple endocrine neoplasia type 2B mutation in human RET oncogene induces medullary thyroid carcinoma in transgenic mice","volume":"19","author":"Acton","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib252","first-page":"5254","article-title":"Tissue-specific carcinogenesis in transgenic mice expressing the RET proto-oncogene with a multiple endocrine neoplasia type 2A mutation","volume":"60","author":"Kawai","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib253","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/emboj\/19.4.612","article-title":"C-cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B","volume":"19","author":"Smith-Hicks","year":"2000","journal-title":"EMBO J"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib254","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1038\/sj.onc.1204434","article-title":"C-cell and thyroid epithelial tumours and altered follicular development in transgenic mice expressing the long isoform of MEN 2A RET","volume":"20","author":"Reynolds","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib255","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s10024001-0039-9","article-title":"RET(MEN 2B)-transgene produces sympathoadrenal tumors but does not prevent intestinal aganglionosis in gdnf\u2212\/\u2212 or gfr alpha-1(\u2212\/\u2212) mice","volume":"4","author":"Rajan","year":"2001","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib256","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0168-9525(96)10012-3","article-title":"RET mutations in human disease","volume":"12","author":"Pasini","year":"1996","journal-title":"Trends Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib257","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/hmg\/6.4.587","article-title":"A duplication of 12bp in the critical cysteine rich domain of the RET proto-oncogene results in a distinct phenotype of multiple endocrine neoplasia type 2A","volume":"6","author":"Hoppner","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib258","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1002\/humu.1380110143","article-title":"Duplication of 9 base pairs in the critical cysteine-rich domain of the RET proto-oncogene causes multiple endocrine neoplasia type 2A","volume":"1","author":"Hoppner","year":"1998","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib259","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1210\/jc.84.10.3522","article-title":"A novel case of multiple endocrine neoplasia type 2A associated with two de novo mutations of the RET protooncogene","volume":"84","author":"Tessitore","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib260","first-page":"6223","article-title":"Duplication of the mutant RET allele in trisomy 10 or loss of the wild-type allele in multiple endocrine neoplasia type 2-associated pheochromocytomas","volume":"60","author":"Huang","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib261","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1210\/jc.2002-021254","article-title":"Amplification and overexpression of mutant RET in multiple endocrine neoplasia type 2-associated medullary thyroid carcinoma","volume":"88","author":"Huang","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib262","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1210\/jc.2004-0041","article-title":"Pheochromocytoma and medullary thyroid carcinoma: a new genotype\u2013phenotype correlation of the RET protooncogene 891 germline mutation","volume":"89","author":"Jimenez","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib263","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1210\/jc.84.5.1700","article-title":"A novel 9-base pair duplication in RET exon 8 in familial medullary thyroid carcinoma","volume":"84","author":"Pigny","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib264","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.1210\/jc.2003-030997","article-title":"A novel germ-line point mutation in RET exon 8 (Gly(533)Cys) in a large kindred with familial medullary thyroid carcinoma","volume":"88","author":"Da Silva","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib265","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/jmg.38.11.784","article-title":"Familial medullary thyroid carcinoma and prominent corneal nerves associated with the germline V804M and V778I mutations on the same allele of RET","volume":"38","author":"Kasprzak","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib266","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/sj.onc.1201481","article-title":"Germline mutation of RET codon 883 in two cases of de novo MEN 2B","volume":"15","author":"Smith","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib267","first-page":"1076","article-title":"Parent-of-origin effects in multiple endocrine neoplasia type 2B","volume":"55","author":"Carlson","year":"1994","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib268","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1349-7006.1999.tb00658.x","article-title":"Two germline missense mutations at codons 804 and 806 of the RET proto-oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutation","volume":"90","author":"Miyauchi","year":"1999","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib269","first-page":"391","article-title":"The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype","volume":"57","author":"Carlomagno","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib270","first-page":"2870","article-title":"Biological properties of Ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype","volume":"57","author":"Ito","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib271","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1038\/sj.onc.1202202","article-title":"Dual effect on the RET receptor of MEN 2 mutations affecting specific extracytoplasmic cysteines","volume":"17","author":"Chappuis-Flament","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib272","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/sj.onc.1201199","article-title":"Oncogenic activation of RET by two distinct FMTC mutations affecting the tyrosine kinase domain","volume":"15","author":"Pasini","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib273","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1038\/sj.onc.1202742","article-title":"Biological and biochemical properties of Ret with kinase domain mutations identified in multiple endocrine neoplasia type 2B and familial medullary thyroid carcinoma","volume":"18","author":"Iwashita","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib274","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/369502a0","article-title":"SH2 domain specificity and activity modified by a single residue","volume":"369","author":"Marengere","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib275","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/373536a0","article-title":"Catalytic specificity of protein-tyrosine kinases is critical for selective signalling","volume":"373","author":"Songyang","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib276","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1074\/jbc.271.10.5850","article-title":"The multiple endocrine neoplasia type 2B point mutation alters long-term regulation and enhances the transforming capacity of the epidermal growth factor receptor","volume":"271","author":"Pandit","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib277","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1006\/bbrc.1999.1186","article-title":"Enhanced phosphatidylinositol 3-kinase activity and high phosphorylation state of its downstream signalling molecules mediated by ret with the MEN 2B mutation","volume":"262","author":"Murakami","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib278","first-page":"1426","article-title":"Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B","volume":"61","author":"Salvatore","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib279","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1038\/sj.onc.1201759","article-title":"Full activation of MEN 2B mutant RET by an additional MEN 2A mutation or by ligand GDNF stimulation","volume":"16","author":"Bongarzone","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib280","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/gcc.1205","article-title":"Novel germline RET mutation segregating with papillary thyroid carcinomas","volume":"32","author":"Rey","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib281","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0002-9440(10)63316-0","article-title":"The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma","volume":"165","author":"Melillo","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib282","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1067\/msy.2000.107103","article-title":"Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG\u2192ATG) mutation","volume":"28","author":"Feldman","year":"2000","journal-title":"Surgery"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib283","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1089\/105072502320288393","article-title":"Papillary thyroid carcinoma in patients with RET proto-oncogene germline mutation","volume":"12","author":"Brauckhoff","year":"2002","journal-title":"Thyroid"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib284","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12022-003-0020-4","article-title":"Concurrent lymph node metastases of medullary and papillary thyroid carcinoma in a case with RET oncogene germline mutation","volume":"14","author":"Papi","year":"2003","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib285","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF03343809","article-title":"RET proto-oncogene mutation in a mixed medullary-follicular thyroid carcinoma","volume":"24","author":"Orlandi","year":"2001","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib286","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/1097-0142(19940801)74:3<928::AID-CNCR2820740321>3.0.CO;2-E","article-title":"Thyroid medullary carcinoma with thyroglobulin immunoreactivity in sporadic multiple endocrine neoplasia type 2-B","volume":"74","author":"Kovacs","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib287","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1200\/JCO.2001.19.5.1374","article-title":"Estimation of risk of inherited medullary thyroid carcinoma in apparent sporadic patients","volume":"19","author":"Wiench","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib288","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/ijc.10298","article-title":"Genetic analysis of RET, GFR alpha 1 and GDNF genes in Spanish families with multiple endocrine neoplasia type 2A","volume":"99","author":"Gil","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib289","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/sj.onc.1207826","article-title":"A model for GFRalpha4 function and a potential modifying role in multiple endocrine neoplasia 2","volume":"24","author":"Vanhorne","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib290","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/3.8.1259","article-title":"Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC:s","volume":"3","author":"Zedenius","year":"1994","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib291","first-page":"509","article-title":"A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC","volume":"10","author":"Eng","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib292","first-page":"2167","article-title":"Heterogeneous mutation of the RET proto-oncogene in subpopulations of medullary thyroid carcinoma","volume":"56","author":"Eng","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib293","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-2265.1996.681503.x","article-title":"Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma","volume":"44","author":"Marsh","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib294","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1210\/jc.81.4.1619","article-title":"Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence","volume":"81","author":"Romei","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib295","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1530\/eje.0.1360423","article-title":"Molecular analysis of the RET proto-oncogene in patients with sporadic medullary thyroid carcinoma: a novel point mutation in the extracellular cysteine-rich domain","volume":"136","author":"Bugalho","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib296","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s100380050048","article-title":"Mutational analysis of the RET proto-oncogene in 71 Japanese patients with medullary thyroid carcinoma","volume":"43","author":"Shirahama","year":"1998","journal-title":"J Hum Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib297","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s001090100250","article-title":"Three novel mutations in the RET proto-oncogene","volume":"79","author":"Kalinin","year":"2001","journal-title":"J Mol Med"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib298","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/1097-0215(20010120)95:1<62::AID-IJC1011>3.0.CO;2-1","article-title":"Prognostic value of codon 918 (ATG\u2192ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinoma","volume":"95","author":"Schilling","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib299","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1365-2796.1998.00375.x","article-title":"Clinical management of the multiple endocrine neoplasia syndromes: results of a computerized opinion poll at the Sixth International Workshop on Multiple Endocrine Neoplasia and von Hippel-Lindau disease","volume":"243","author":"Lips","year":"1998","journal-title":"J Intern Med"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib300","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s004320000173","article-title":"Diagnosis and therapy of sporadic and familial medullary thyroid carcinoma","volume":"127","author":"Gimm","year":"2001","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib301","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1023\/A:1012593410510","article-title":"Quality of life in patients at risk of medullary thyroid carcinoma and followed by a comprehensive medical network: trends for future evaluations","volume":"12","author":"Freyer","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib302","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1046\/j.1365-2796.2003.01166.x","article-title":"Surgical treatment of medullary thyroid carcinoma","volume":"253","author":"Cohen","year":"2003","journal-title":"J Intern Med"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib303","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s002680010166","article-title":"Medullary carcinoma of the thyroid gland","volume":"24","author":"Wells","year":"2000","journal-title":"World J Surg"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib304","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/jnci\/djh214","article-title":"Evolving strategies for targeted cancer therapy\u2014past, present, and future","volume":"96","author":"Wells","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib305","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1677\/joe.1.05895","article-title":"How thyroid tumors start and why it matters: kinase mutants as targets for solid cancer pharmacotherapy","volume":"183","author":"Fagin","year":"2004","journal-title":"J Endocrinol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib306","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1067\/msy.2002.128562","article-title":"Inhibition of medullary thyroid carcinoma cell proliferation and RET phosphorylation by tyrosine kinase inhibitors","volume":"132","author":"Cohen","year":"2002","journal-title":"Surgery"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib307","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/(SICI)1097-0215(20000201)85:3<384::AID-IJC15>3.0.CO;2-Y","article-title":"Inhibition of transforming activity of the ret\/ptc1 oncoprotein by a 2-indolinone derivative","volume":"85","author":"Lanzi","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib308","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00018-003-2381-8","article-title":"Inactivation of Ret\/Ptc1 oncoprotein and inhibition of papillary thyroid carcinoma cell proliferation by indolinone RPI-1","volume":"60","author":"Lanzi","year":"2003","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib309","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1158\/1078-0432.1336.11.3","article-title":"Dual inhibition of RET and FGFR4 restrains medullary thyroid cancer cell growth","volume":"11","author":"Ezzat","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib310","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/jnci\/djh184","article-title":"Cellular effects and antitumor activity of RET inhibitor RPI-1 on MEN 2A-associated medullary thyroid carcinoma","volume":"96","author":"Cuccuru","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib311","first-page":"5559","article-title":"CEP-701 and CEP-751 inhibit constitutively activated RET tyrosine kinase activity and block medullary thyroid carcinoma cell growth","volume":"63","author":"Strock","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib312","first-page":"1077","article-title":"The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes","volume":"62","author":"Carlomagno","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib313","first-page":"2234","article-title":"PP1 inhibitor induces degradation of RETMEN 2A and RETMEN 2B oncoproteins through proteosomal targeting","volume":"63","author":"Carniti","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib314","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/jc.2002-021278","article-title":"Efficient inhibition of RET\/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2)","volume":"88","author":"Carlomagno","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib315","first-page":"7284","article-title":"ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases","volume":"62","author":"Carlomagno","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib316","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1038\/sj.onc.1207810","article-title":"Disease associated mutations at valine 804 in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitors","volume":"23","author":"Carlomagno","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib317","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1042\/bj20021530","article-title":"The soluble ectodomain of RetC634Y inhibits both the wild-type and the constitutively active Ret","volume":"372","author":"Cerchia","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib318","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1067\/msy.2002.128560","article-title":"A new therapeutic approach in medullary thyroid cancer treatment: inhibition of oncogenic RET signaling by adenoviral vector-mediated expression of a dominant-negative RET mutant","volume":"132","author":"Drosten","year":"2002","journal-title":"Surgery"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib319","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1089\/104303403766682232","article-title":"Antitumor capacity of a dominant-negative RET proto-oncogene mutant in a medullary thyroid carcinoma model","volume":"14","author":"Drosten","year":"2003","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib320","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/jnci\/djh226","article-title":"Role of MEN 2A-derived RET in maintenance and proliferation of medullary thyroid carcinoma","volume":"96","author":"Drosten","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib321","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/00008480-200012000-00017","article-title":"Genetics of Hirschsprung disease","volume":"12","author":"Parisi","year":"2000","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib322","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJM199604253341707","article-title":"The enteric nervous system","volume":"334","author":"Goyal","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib323","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0959-4388(97)80127-4","article-title":"Genes and lineages in the formation of the enteric nervous system","volume":"7","author":"Gershon","year":"1997","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib324","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0959-437X(99)80048-3","article-title":"Development of the mammalian enteric nervous system","volume":"9","author":"Taraviras","year":"1999","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib325","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/jmg.38.11.729","article-title":"Hirschsprung disease, associated syndromes, and genetics: a review","volume":"38","author":"Amiel","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib326","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/jmg.31.8.602","article-title":"Long segment and short segment familial Hirschsprung's disease: variable clinical expression at the RET locus","volume":"31","author":"Edery","year":"1994","journal-title":"J Med Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib327","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/hmg\/4.5.821","article-title":"Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease","volume":"4","author":"Angrist","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib328","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/hmg\/4.8.1381","article-title":"Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease","volume":"4","author":"Atti\u00e9","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib329","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJM199609263351307","article-title":"The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease","volume":"335","author":"Eng","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib330","first-page":"217","article-title":"Investigation of germline GFR alpha-1 mutations in Hirschsprung disease","volume":"36","author":"Myers","year":"1999","journal-title":"J Med Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib331","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1086\/338712","article-title":"Gdnf haploinsufficiency causes Hirschsprung-like intestinal obstruction and early-onset lethality in mice","volume":"70","author":"Shen","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib332","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/hmg\/10.14.1503","article-title":"Loss-of-function mutations in SIP1 Smad interacting protein 1 result in a syndromic Hirschsprung disease","volume":"10","author":"Cacheux","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib333","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/86860","article-title":"Mutations in SIP1, encoding Smad interacting protein-1, cause a form of Hirschsprung disease","volume":"27","author":"Wakamatsu","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib334","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1073\/pnas.97.1.268","article-title":"A human model for multigenic inheritance: phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus","volume":"97","author":"Bolk","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib335","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/ng868","article-title":"Segregation at three loci explains familial and population risk in Hirschsprung disease","volume":"31","author":"Gabriel","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib336","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/jmg.36.10.771","article-title":"Specific polymorphisms in the RET proto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression","volume":"36","author":"Borrego","year":"1999","journal-title":"J Med Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib337","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/jmg.37.8.572","article-title":"RET genotypes comprising specific haplotypes of polymorphic variants predispose to isolated Hirschsprung disease","volume":"37","author":"Borrego","year":"2000","journal-title":"J Med Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib338","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1086\/345466","article-title":"A founding locus within the RET proto-oncogene may account for a large proportion of apparently sporadic Hirschsprung disease and a subset of cases of sporadic medullary thyroid carcinoma","volume":"72","author":"Borrego","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib339","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/gut.48.5.671","article-title":"Analysis of the RET, GDNF, EDN3, and EDNRB genes in patients with intestinal neuronal dysplasia and Hirschsprung disease","volume":"48","author":"Gath","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib340","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1086\/302618","article-title":"Association of RET protooncogene codon 45 polymorphism with Hirschsprung disease","volume":"65","author":"Fitze","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib341","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0140-6736(02)08218-1","article-title":"Association between c135G\/A genotype and RET proto-oncogene germline mutations and phenotype of Hirschsprung's disease","volume":"359","author":"Fitze","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib342","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/humu.9161","article-title":"Novel intronic polymorphisms in the RET proto-oncogene and their association with Hirschsprung disease","volume":"22","author":"Fitze","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib343","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/jmg.40.9.714","article-title":"Single nucleotide polymorphic alleles in the 5\u2032 region of the RET proto-oncogene define a risk haplotype in Hirschsprung's disease","volume":"40","author":"Sancandi","year":"2003","journal-title":"J Med Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib344","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s10024-001-0142-y","article-title":"Enteric nervous system: development and developmental disturbances","volume":"5","author":"Newgreen","year":"2002","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib345","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/ng998","article-title":"Genome-wide association study and mouse model identify interaction between RET and EDNRB pathways in Hirschsprung disease","volume":"32","author":"Carrasquillo","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib346","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1073\/pnas.0337540100","article-title":"Phenotype variation in two-locus mouse models of Hirschsprung disease: tissue-specific interaction between Ret and Ednrb","volume":"100","author":"McCallion","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib347","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1126\/science.1085649","article-title":"Hirschsprung disease is linked to defects in neural crest stem cell function","volume":"301","author":"Iwashita","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib348","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0896-6273(03)00727-X","article-title":"Temporally distinct requirements for endothelin receptor B in the generation and migration of gut neural crest stem cells","volume":"40","author":"Kruger","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib349","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0896-6273(03)00730-X","article-title":"Enteric nervous system progenitors are coordinately controlled by the G protein-coupled receptor EDNRB and the receptor tyrosine kinase RET","volume":"40","author":"Barlow","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib350","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/(SICI)1098-1004(1997)9:2<97::AID-HUMU1>3.0.CO;2-M","article-title":"Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease","volume":"9","author":"Eng","year":"1997","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib351","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1053\/gast.2001.25515","article-title":"Functional analysis of RET with Hirschsprung mutations affecting its kinase domain","volume":"121","author":"Iwashita","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib352","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1172\/JCI375","article-title":"Various mechanisms cause RET-mediated signaling defects in Hirschsprung's disease","volume":"101","author":"Pelet","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib353","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/j.1460-2075.1996.tb00632.x","article-title":"Molecular heterogeneity of RET loss of function in Hirschsprung's disease","volume":"15","author":"Carlomagno","year":"1996","journal-title":"EMBO J"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib354","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/hmg\/5.10.1577","article-title":"Mechanism of ret dysfunction by Hirschsprung mutations affecting its extracellular domain","volume":"5","author":"Iwashita","year":"1996","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib355","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1210\/me.2003-0173","article-title":"Biological effects of the dual phenotypic Janus mutation of ret cosegregating with both multiple endocrine neoplasia type 2 and Hirschsprung's disease","volume":"18","author":"Arighi","year":"2004","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib356_1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/(SICI)1098-1004(1999)13:4<331::AID-HUMU11>3.0.CO;2-#","article-title":"Co-segregation of MEN2 and Hirschsprung's disease: the same mutation of RET with both gain and loss-of-function?","volume":"13","author":"Takahashi","year":"1999","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib356_2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/ng0595-35","article-title":"Loss of function effect of RET mutations causing Hirschsprung disease","volume":"10","author":"Pasini","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib357_1","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1093\/hmg\/8.11.1989","article-title":"Two distinct mutations of the RET receptor causing Hirschsprung's disease impair the binding of signalling effectors to a multifunctional docking site","volume":"8","author":"Geneste","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib357_2","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1128\/MCB.18.6.3321","article-title":"Mutations in the extracellular domain cause RET loss of function by a dominant negative mechanism","volume":"18","author":"Cosma","year":"1998","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib358","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1093\/emboj\/19.15.4056","article-title":"The RET proto-oncogene induces apoptosis: a novel mechanism for Hirschsprung disease","volume":"19","author":"Bordeaux","year":"2000","journal-title":"EMBO J"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib359","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2796.1995.tb01208.x","article-title":"Genotype\u2013phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium","volume":"238","author":"Mulligan","year":"1995","journal-title":"J Intern Med"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib360","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1210\/jc.87.6.2994-a","article-title":"Occurrence of pheochromocytoma in a MEN 2A family with codon 609 mutation of the RET proto-oncogene","volume":"87","author":"Igaz","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib361","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/sj.ejhg.5200971","article-title":"Cys611Ser mutation in RET proto-oncogene in a kindred with medullary thyroid carcinoma and Hirschsprung's disease","volume":"11","author":"Nishikawa","year":"2003","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib362","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1507\/endocrj.43.25","article-title":"A family of multiple endocrine neoplasia type 2A: genetic analysis and clinical features","volume":"43","author":"Morita","year":"1996","journal-title":"Endocr J"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib363","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1006\/geno.1994.1526","article-title":"A rapid screening method for the detection of mutations in the RET proto-oncogene in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma families","volume":"23","author":"Marsh","year":"1994","journal-title":"Genomics"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib364","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1507\/endocrj.42.527","article-title":"Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A (Sipple's syndrome)","volume":"42","author":"Oishi","year":"1995","journal-title":"Endocr J"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib365","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/1097-0142(19950801)76:3<479::AID-CNCR2820760319>3.0.CO;2-M","article-title":"Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas","volume":"76","author":"Komminoth","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib366","article-title":"Novel germline mutation in the transmembrane region of RET gene close to Cys634Ser mutation associated with MEN 2A syndrome","author":"Poturnajova","year":"2004","journal-title":"J Mol Med"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib367","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1210\/jc.83.3.770","article-title":"A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A","volume":"83","author":"Berndt","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib368","first-page":"2415","article-title":"RET mutations in exons 13 and 14 of FMTC patients","volume":"10","author":"Bolino","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib369","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1002\/humu.1380110156","article-title":"A GTG to ATG novel point mutation at codon 804 in exon 14 of the RET proto-oncogene in two families affected by familial medullary thyroid carcinoma","volume":"1","author":"Fattoruso","year":"1998","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cytogfr.2005.05.010_bib370","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1210\/jc.82.12.4176","article-title":"A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinoma","volume":"82","author":"Hofstra","year":"1997","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610105000742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610105000742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T15:29:57Z","timestamp":1683127797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610105000742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":372,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S1359610105000742"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2005.05.010","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}